Chemed Net Profit Margin 2010-2024 | CHE

Current and historical net profit margin for Chemed (CHE) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Chemed net profit margin for the three months ending September 30, 2024 was .
Chemed Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $2.38B $0.30B 12.71%
2024-06-30 $2.34B $0.30B 12.89%
2024-03-31 $2.29B $0.28B 12.34%
2023-12-31 $2.27B $0.27B 12.01%
2023-09-30 $2.23B $0.24B 10.96%
2023-06-30 $2.19B $0.23B 10.33%
2023-03-31 $2.16B $0.24B 11.04%
2022-12-31 $2.14B $0.25B 11.66%
2022-09-30 $2.13B $0.26B 12.31%
2022-06-30 $2.14B $0.28B 12.93%
2022-03-31 $2.14B $0.27B 12.51%
2021-12-31 $2.14B $0.27B 12.58%
2021-09-30 $2.13B $0.31B 14.45%
2021-06-30 $2.12B $0.30B 14.34%
2021-03-31 $2.09B $0.33B 15.74%
2020-12-31 $2.08B $0.32B 15.39%
2020-09-30 $2.07B $0.27B 13.15%
2020-06-30 $2.02B $0.26B 13.01%
2020-03-31 $1.99B $0.23B 11.64%
2019-12-31 $1.94B $0.22B 11.40%
2019-09-30 $1.88B $0.21B 11.15%
2019-06-30 $1.84B $0.20B 10.94%
2019-03-31 $1.81B $0.21B 11.35%
2018-12-31 $1.78B $0.21B 11.50%
2018-09-30 $1.75B $0.21B 11.75%
2018-06-30 $1.73B $0.19B 11.01%
2018-03-31 $1.70B $0.11B 6.65%
2017-12-31 $1.67B $0.10B 5.88%
2017-09-30 $1.64B $0.08B 4.57%
2017-06-30 $1.62B $0.07B 4.14%
2017-03-31 $1.59B $0.11B 7.16%
2016-12-31 $1.58B $0.11B 6.92%
2016-09-30 $1.57B $0.11B 6.81%
2016-06-30 $1.57B $0.11B 6.96%
2016-03-31 $1.56B $0.11B 7.13%
2015-12-31 $1.54B $0.11B 7.19%
2015-09-30 $1.52B $0.11B 7.28%
2015-06-30 $1.50B $0.11B 7.15%
2015-03-31 $1.47B $0.10B 7.06%
2014-12-31 $1.46B $0.10B 6.87%
2014-09-30 $1.43B $0.09B 6.53%
2014-06-30 $1.41B $0.09B 6.04%
2014-03-31 $1.41B $0.08B 5.41%
2013-12-31 $1.41B $0.08B 5.45%
2013-09-30 $1.43B $0.08B 5.65%
2013-06-30 $1.45B $0.09B 5.87%
2013-03-31 $1.44B $0.09B 6.30%
2012-12-31 $1.43B $0.09B 6.22%
2012-09-30 $1.41B $0.09B 6.24%
2012-06-30 $1.40B $0.09B 6.37%
2012-03-31 $1.38B $0.09B 6.39%
2011-12-31 $1.36B $0.09B 6.35%
2011-09-30 $1.34B $0.08B 6.19%
2011-06-30 $1.32B $0.08B 6.21%
2011-03-31 $1.30B $0.08B 6.22%
2010-12-31 $1.28B $0.08B 6.41%
2010-09-30 $1.25B $0.08B 6.17%
2010-06-30 $1.22B $0.08B 6.13%
2010-03-31 $1.20B $0.07B 6.06%
2009-12-31 $1.19B $0.07B 6.13%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.277B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00